Chinese study tests tailored bypass strategy for moyamoya disease

By AI, Created 4:50 PM UTC, May 18, 2026, /AGP/ – A multicenter Chinese study of 303 adults suggests that a vessel-preserving, patient-specific revascularization strategy can keep bypasses open, improve brain perfusion and lower recurrent stroke risk in moyamoya disease. The findings, published in the Chinese Neurosurgical Journal, point to a more individualized surgical path for a progressive condition that often strikes adults in their working years.

Why it matters: - Moyamoya disease narrows major brain arteries and raises the risk of stroke, brain hemorrhage and cognitive decline. - A surgical approach that preserves the superficial temporal artery could improve blood flow without sacrificing long-term donor vessel function. - The study suggests a practical way to tailor revascularization to vessel size and brain blood-flow needs.

What happened: - A Chinese research team evaluated a new cerebral revascularization strategy called the superficial temporal artery patency concept, or STAPC. - The study was published in the Chinese Neurosurgical Journal on Feb. 26, 2026. - The multicenter retrospective study included 303 adult patients treated at two Chinese medical centers from 2019 to 2021. - Professor Yongbo Yang of Nanjing University Medical School and Dr. Dong Zhang of Beijing Hospital led the work. - The DOI is https://doi.org/10.1186/s41016-025-00424-4.

The details: - STAPC centers surgical planning on preserving the superficial temporal artery. - The approach uses vessel diameter, blood-flow dynamics and the condition of recipient brain arteries to choose direct bypass, indirect bypass or a combined procedure. - Among the 303 patients, 170 received combined superficial temporal artery-middle cerebral artery bypass plus encephalo-duro-arterio-synangiosis. - The remaining 133 underwent indirect bypass surgery alone. - The team used CT angiography to assess bypass patency. - The team used CT perfusion imaging to measure blood-flow recovery. - The team also tracked patients long term for recurrent stroke events. - More than 95% of bypasses remained open at 3 months and at 12 months after surgery. - Brain perfusion improved in nearly one-quarter of patients at 3 months. - Brain perfusion improved in more than 40% of patients at 1 year. - Perfusion gains were stronger in the combined bypass group. - Over a median follow-up of 50 months, recurrent stroke events occurred at an annual rate below 4%.

Between the lines: - The results support a shift away from one-size-fits-all bypass planning in moyamoya disease. - The study also suggests that real-time flow assessment and vessel matching may shape future cerebrovascular surgery beyond this one condition. - The authors say future prospective randomized studies are still needed, so the findings are promising but not definitive.

What’s next: - Surgeons may use STAPC as a framework for more individualized brain revascularization. - The authors say better imaging and multicenter evidence could refine how clinicians choose the right operation for each patient. - Future collaborations among neurosurgeons, imaging specialists, biomedical engineers and data scientists could improve patient selection and intraoperative decisions. - The researchers suggest that broader adoption of personalized revascularization could reduce disability, preserve independence and lower long-term stroke-care costs.

The bottom line: - The Chinese study points to a durable, vessel-preserving bypass strategy that may improve stroke prevention in moyamoya disease while protecting artery function.